383 related articles for article (PubMed ID: 28648526)
1. Applying Structure-Based Drug Design Approaches to Allosteric Modulators of GPCRs.
Congreve M; Oswald C; Marshall FH
Trends Pharmacol Sci; 2017 Sep; 38(9):837-847. PubMed ID: 28648526
[TBL] [Abstract][Full Text] [Related]
2. Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.
Lu S; Zhang J
J Med Chem; 2019 Jan; 62(1):24-45. PubMed ID: 29457894
[TBL] [Abstract][Full Text] [Related]
3. Novel Allosteric Modulators of G Protein-coupled Receptors.
Gentry PR; Sexton PM; Christopoulos A
J Biol Chem; 2015 Aug; 290(32):19478-88. PubMed ID: 26100627
[TBL] [Abstract][Full Text] [Related]
4. Allosteric Modulators of the Class A G Protein Coupled Receptors.
Tschammer N
Adv Exp Med Biol; 2016; 917():185-207. PubMed ID: 27236557
[TBL] [Abstract][Full Text] [Related]
5. Allosteric modulation of family C G-protein-coupled receptors: from molecular insights to therapeutic perspectives.
Urwyler S
Pharmacol Rev; 2011 Mar; 63(1):59-126. PubMed ID: 21228259
[TBL] [Abstract][Full Text] [Related]
6. Structural Basis for Allosteric Modulation of Class B G Protein-Coupled Receptors.
Wootten D; Miller LJ
Annu Rev Pharmacol Toxicol; 2020 Jan; 60():89-107. PubMed ID: 31454292
[TBL] [Abstract][Full Text] [Related]
7. Allosteric modulation of GPCRs: From structural insights to in silico drug discovery.
Persechino M; Hedderich JB; Kolb P; Hilger D
Pharmacol Ther; 2022 Sep; 237():108242. PubMed ID: 35863587
[TBL] [Abstract][Full Text] [Related]
8. GPCR structures in drug design, emerging opportunities with new structures.
Tautermann CS
Bioorg Med Chem Lett; 2014 Sep; 24(17):4073-9. PubMed ID: 25086683
[TBL] [Abstract][Full Text] [Related]
9. Emerging opportunities for allosteric modulation of G-protein coupled receptors.
Wang CI; Lewis RJ
Biochem Pharmacol; 2013 Jan; 85(2):153-62. PubMed ID: 22975406
[TBL] [Abstract][Full Text] [Related]
10. Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.
Janero DR; Thakur GA
Expert Opin Drug Discov; 2016 Dec; 11(12):1223-1237. PubMed ID: 27712124
[TBL] [Abstract][Full Text] [Related]
11. Potential for the Rational Design of Allosteric Modulators of Class C GPCRs.
Christopher JA; Doré AS; Tehan BG
Curr Top Med Chem; 2017; 17(1):71-78. PubMed ID: 27448651
[TBL] [Abstract][Full Text] [Related]
12. Class A GPCRs: Structure, Function, Modeling and Structure-based Ligand Design.
Cong X; Topin J; Golebiowski J
Curr Pharm Des; 2017 Nov; 23(29):4390-4409. PubMed ID: 28699533
[TBL] [Abstract][Full Text] [Related]
13. Allosteric modulation of kinases and GPCRs: design principles and structural diversity.
Lewis JA; Lebois EP; Lindsley CW
Curr Opin Chem Biol; 2008 Jun; 12(3):269-80. PubMed ID: 18342020
[TBL] [Abstract][Full Text] [Related]
14. Functional and structural perspectives on allosteric modulation of GPCRs.
Langmead CJ; Christopoulos A
Curr Opin Cell Biol; 2014 Apr; 27():94-101. PubMed ID: 24680434
[TBL] [Abstract][Full Text] [Related]
15. Integrated In Silico Fragment-Based Drug Design: Case Study with Allosteric Modulators on Metabotropic Glutamate Receptor 5.
Bian Y; Feng Z; Yang P; Xie XQ
AAPS J; 2017 Jul; 19(4):1235-1248. PubMed ID: 28560482
[TBL] [Abstract][Full Text] [Related]
16. Current and Future Challenges in GPCR Drug Discovery.
Topiol S
Methods Mol Biol; 2018; 1705():1-21. PubMed ID: 29188556
[TBL] [Abstract][Full Text] [Related]
17. Intracellular Receptor Modulation: Novel Approach to Target GPCRs.
Ortiz Zacarías NV; Lenselink EB; IJzerman AP; Handel TM; Heitman LH
Trends Pharmacol Sci; 2018 Jun; 39(6):547-559. PubMed ID: 29653834
[TBL] [Abstract][Full Text] [Related]
18. Covalent allosteric modulation: An emerging strategy for GPCRs drug discovery.
Bian Y; Jun JJ; Cuyler J; Xie XQ
Eur J Med Chem; 2020 Nov; 206():112690. PubMed ID: 32818870
[TBL] [Abstract][Full Text] [Related]
19. Allosteric modulation of G-protein coupled receptors.
Jensen AA; Spalding TA
Eur J Pharm Sci; 2004 Mar; 21(4):407-20. PubMed ID: 14998571
[TBL] [Abstract][Full Text] [Related]
20. Allosteric modulators of rhodopsin-like G protein-coupled receptors: opportunities in drug development.
Müller CE; Schiedel AC; Baqi Y
Pharmacol Ther; 2012 Sep; 135(3):292-315. PubMed ID: 22728155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
